Enterocutaneous fistula and drugs of ingredients of gabapentin - a phase IV clinical study of FDA data

---

---

Number of reports submitted per year:

Time on drugs with ingredients of gabapentin when people have Enterocutaneous fistula *:

• < 1 month: 0.0 %
• 1 - 6 months: 0.0 %
• 6 - 12 months: 0.0 %
• 1 - 2 years: 0.0 %
• 2 - 5 years: 100 %
• 5 - 10 years: 0.0 %
• 10+ years: 0.0 %

Gender of people who have Enterocutaneous fistula when taking drugs with ingredients of gabapentin *:

• female: 60 %
• male: 40 %

Age of people who have Enterocutaneous fistula when taking drugs with ingredients of gabapentin *:

• 0-1: 0.0 %
• 2-9: 0.0 %
• 10-19: 0.0 %
• 20-29: 27.27 %
• 30-39: 13.64 %
• 40-49: 9.09 %
• 50-59: 4.55 %
• 60+: 45.45 %

Conditions people have *:

1. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 14 people, 48.28%
2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 13.79%
3. Nausea (feeling of having an urge to vomit): 3 people, 10.34%
4. Stress And Anxiety: 2 people, 6.90%
5. Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 6.90%
6. Hypersensitivity: 2 people, 6.90%
7. Colon Cancer: 2 people, 6.90%
8. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 6.90%
9. Central Pain Syndrome (neurological condition caused by damage or malfunction in the central nervous system): 1 person, 3.45%
10. Colon Cancer Metastatic (cancer of colon spreads to other part of body): 1 person, 3.45%

Other drugs people take *:

1. Celebrex: 8 people, 27.59%
2. Humira: 5 people, 17.24%
3. Levothyroxine Sodium: 4 people, 13.79%
4. Oxycodone: 4 people, 13.79%
5. Carbamazepine: 3 people, 10.34%
6. Cholestyramine: 3 people, 10.34%
7. Cimzia: 3 people, 10.34%
8. Cymbalta: 3 people, 10.34%
9. Escitalopram: 3 people, 10.34%
10. Folic Acid: 3 people, 10.34%

Other side effects people have besides Enterocutaneous fistula *:

1. Anal Fistula: 8 people, 27.59%
2. Dehydration (dryness resulting from the removal of water): 6 people, 20.69%
3. Chills (felling of cold): 4 people, 13.79%
4. Weight Decreased: 3 people, 10.34%
5. General Physical Health Deterioration (weak health status): 3 people, 10.34%
6. Abdominal Pain: 3 people, 10.34%
7. Anaemia (lack of blood): 3 people, 10.34%
8. Angiocentric Lymphoma (extra nodal natural killer cell cancer): 3 people, 10.34%
9. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 10.34%
10. Device Related Infection: 3 people, 10.34%

---